Diabetes

kind-spielt-institut-fotoshooting-nozy-andreas pfohl-220727_0587 mit Logofr1da

Starting May 1, 2025, the pioneering study “Fr1da” for early detection of type 1 diabetes will expand into the German states of Hesse and Rhineland-Palatinate. Pediatric practices in these regions will then be able to offer families with children…

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and diabetes. Surprisingly, active substances are currently being developed that not only activate the GIP receptor (agonists) but…

A new study, led by Prof. Eleftheria Zeggini, Director of the Institute of Translational Genomics at Helmholtz Munich, and Prof. Anette-Gabriele Ziegler, Director of the Institute of Diabetes Research at Helmholtz Munich, has revealed a significant…

Scientists from the German Mouse Clinic at the Institute of Experimental Genetics (Helmholtz Munich) have studied the effects of a missing gene, Ten1, on aging. By generating a mouse model with Ten1 deficiency, researchers observed that without this…

A new study has identified KLK7, a protein found in immune cells, as a key driver of obesity-related inflammation and metabolic disorders. Led by PD Dr. John Heiker and Dr. Aleix Ribas-Latre from the Helmholtz Institute for Metabolic, Obesity and…